Patients & Visitors ›

Profile

Profile
Research

Marina Nunez, M.D., Ph.D.

Associate Professor, Infectious Diseases
Gastroenterology

Clinical Specialties

Infectious Diseases, Human Immunodeficiency Virus (HIV) Infection, Hepatitis

Contact Information

Department: 336-716-4395

Insurance Accepted »

Additional Languages

Spanish

Education & Training

M.D., Univ Navarra Faculty of Medicine-Spain , 1988
Ph.D., Univ Navarra Faculty of Medicine-Spain , 1996
Residency, Internal Medicine, Univ Navarra Faculty of Medicine-Spain, 1994
Fellowship, Infectious Disease, WFU School of Medicine, 1998

NPI Number

1700815479

Marina Nunez, M.D., Ph.D.

Associate Professor, Infectious Diseases Gastroenterology

Research Interests

infectious diseases, minority health issues

Contact Information

Academic: 336-716-4512 | Department: 336-716-4395

Recent Publications

Barbour S, Bachmann L, Nunez M. Transient hepatitis B surface antigenemia after hepatitis B virus vaccine in an HIV-infected patient [letter]. AIDS Res Hum Retroviruses. 2013;29(4):639-640.

Jones M, Nunez M. Liver toxicity of antiretroviral drugs. Semin Liver Dis. 2012;32(2):167-176.

Freedman BI, Langefeld CD, Turner J, Nunez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease. Kidney Int. 2012;82(7):805-811.

Lamar ZS, Nunez M. Higher risk of severe drug-induced liver injury among Hispanic HIV-infected patients after initiation of highly active antiretroviral therapy. J Int Assoc Physicians AIDS Care (Chic Ill). 2011;10(3):183-186.

Connoy A, Turner J, Nunez M. Levels of serum markers of liver inflammation and fibrosis in patients with chronic hepatitis C virus infection according to HIV status and antiretroviral use. AIDS Res Hum Retroviruses. 2011;27(7):719-725.

Jones M, Nunez M. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management. Curr Opin HIV AIDS. 2011;6(6):546-552.

Shores N, Mendes-Correa MC, Maida I, Turner J, Uip DE, High K, Nunez M. Hepatic PPAR gamma expression is further impaired in HCV-infected subjects with HIV-co-infection [abstract]. Hepatology. 2011;54(Suppl 1):1331A.

Nunez M, Saran AM, Freedman BI. Gene-gene and gene-environment interactions in HIV-associated nephropathy: a focus on the MYH9 nephropathy susceptibility gene. Adv Chronic Kidney Dis. 2010;17(1):44-51.

Shores NJ, Maida I, Perez-Saleme L, Nunez M. Virological rather than host factors are associated with transaminase levels among HIV/HCV-coinfected patients. J Int Assoc Physicians AIDS Care (Chic Ill). 2010;9(1):15-19.

Nunez M. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence [letter]. Hepatology. 2010;51(3):1087-1088.

Brau N, Kikuchi L, Nunez M, Barreiro P, Nelson M, Bini EJ, Kristen M, Fox R, Sherman M, Puoti M. Improved survival of hepatocellular carcinoma (HCC) in HIV-infected patients with undetectalbe HIV RNA [abstract]. J Hepatol. 2010;52(Suppl 1):S219.

Kikuchi L, Nunez M, Barreiro P, Nelson M, Vispo ME, Page E, Puoti M, Fox R, Sherman M, Carrilho F, et al. Impact of screening for hepatocellular carcinoma (HCC) in HIV/HCV-coinfected patients on staging, therapy and survival [abstract]. J Hepatol. 2010;52(Suppl 1):S412.

Nunez M. Clinical syndromes and consequences of antiretroviral-related hepatotoxicity. Hepatology. 2010;52(3):1143-1155.

Mendes-Correa M, Nunez M. Management of HIV and hepatitis virus coinfection. Expert Opin Pharmacother. 2010;11(15):2497-2516.

Kaplan DE, Daruich J, Jalali Z, Rafiullah, Nunez M, Vogel M, Vispo E, Barreiro P, Rockstroh JK, Mauss S, et al. Age and hepatocellular carcinoma in HIV-infected patients [abstract]. Hepatology. 2010;52(4 Suppl):1174-5A.

Lee T, Nunez M. Longer duration of HBV-active antiretroviral therapy is linked to favorable virological outcome in HIV-HBV co-infected patients. HIV Clin Trials. 2009;10(3):153-159.

Townsend D, Troya J, Maida I, Perez-Saleme L, Satta G, Wilkin A, Barreiro P, Pegram PS, Soriano V, Nunez M, et al. First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome. J Int Assoc Physicians AIDS Care (Chic Ill). 2009;8(5):314-317.

Nunez M, Beltz A, High K. Effect of HIV on levels of serum markers of liver inflammation and fibrosis in hepatitis C virus co-infection [abstract]. Hepatology. 2009;50(4 Suppl):923A-924A.

Maida I, Rios MJ, Perez-Saleme L, Ramos B, Soriano V, Pegram PS, Mura MS, Sanchez-Margalet V, Wilkin A, Nunez M, et al. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. AIDS Res Hum Retroviruses. 2008;24(5):679-683.

Yacisin K, Maida I, Rios MJ, Soriano V, Nunez M. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy. AIDS Res Hum Retroviruses. 2008;24(7):935-940.

Shores NJ, Maida I, Soriano V, Nunez M. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients. J Hepatol. 2008;49(3):323-328.

Soriano V, Rivas P, Nunez M. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions [editorial]. Clin Infect Dis. 2008;47(11):1486-1489.

Nunez M. Response to Cicconi et al. 'Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?' [letter]. AIDS. 2007;21(12):1660.

Nunez M, Miralles C, Berdun MA, Losada E, Aguirrebengoa K, Ocampo A, Arazo P, Cervantes M, De Los Santos I, San Joaquin I, et al. Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO Trial. AIDS Res Hum Retroviruses. 2007;23(8):972-982.

Nunez M, Soriano V, Lopez M, Ballesteros C, Cascajero A, Gonzalez-Lahoz J, Benito JM. Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients [editorial]. Clin Infect Dis. 2006;43(9):1209-1212.

Nunez M, Ramos B, Diaz-Pollan B, Camino N, Martin-Carbonero L, Barreriro P, Gonzalez-Lahoz J, Soriano V. Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy. AIDS Res Hum Retroviruses. 2006;22(9):842-848.

Maida I, Soriano V, Castellares C, Ramos B, Sotgiu G, Martin-Carbonero L, Barreiro P, Rivas P, Gonzalez-Lahoz J, Nunez M. Liver fibrosis in HIV-infected patients with chronic hepatitis B extensively exposed to antiretroviral therapy with anti-HBV activity. HIV Clin Trials. 2006;7(5):246-250.